Bizzell Awarded a Contract to Develop a Curriculum for Treating Alzheimer’s Disease

Bizzell Awarded a Contract to Develop a Curriculum for Treating Alzheimer’s Disease

The Bizzell Group (Bizzell) is pleased to announce that our firm was awarded a multi-year contract with the Health Resources and Services Administration (HRSA) to develop a “Uniform Curriculum for the Identification and Treatment of Alzheimer’s Disease for Primary Care Providers”. In designing a Uniform Curriculum to effectively identify and treat Alzheimer’s disease, Bizzell is developing training along the continuum of learning for health care providers which includes academic and health professional scholastic education for student trainees enrolled in health care training programs (e.g., schools of medicine, nursing, pharmacy, dentistry, and master’s and doctoral-level graduate training programs), continuing medical education and continuing education for geriatric health care professionals.

Alzheimer’s disease is an epidemic that continues to grow as people live to an older age. Experts believe as many as 5.4 million people in the U.S. have Alzheimer’s disease. According to the National Institute on Aging, the number of people with the disease doubles every 5-year interval beyond age 65. Government projections show that the number of people ages 65 and older in the United States is expected to grow from 40 million in 2010 to 72.1 million in 2030.

“Our company is honored to lead this important national effort for the Health Resources and Services Administration”, said Anton Bizzell, MD, CEO of Bizzell. “Alzheimer’s disease was the contributing factor in the loss of both my maternal grandmother and great-grandmother and the work is clearly needed with the number of Americans living with Alzheimer’s disease expected to more than triple by 2050.”

HRSA IDIQ Contract Awarded to Bizzell

HRSA IDIQ Contract Awarded to Bizzell

The Bizzell Group (Bizzell) celebrates the award of a critical Indefinite Delivery-Indefinite Quantity (IDIQ) contract with the Health Resources and Services Administration (HRSA), an agency of the Department of Health and Human Services (HHS), the primary Federal agency for improving access to health care services for people who are uninsured, isolated or medically vulnerable.

Bizzell will provide technical and consultative assistance in support of HRSA grantees, including onsite and off-site visits and technical assistance (TA) for health centers, national cooperative agreements, State/regional primary care associations, FQHC Look-Alikes, universities, community-based programs, AIDS service organizations, grantees, etc.

The contract is intended to enhance overall primary health care program performance and management of grantee activities.  This particular award is perfectly aligned with Bizzell’s extensive experience in health care services and support.

Bizzell CEO Contributes Chapter to The ASAM Principles of Addiction Medicine

Bizzell CEO Contributes Chapter to The ASAM Principles of Addiction Medicine

Anton Bizzell, M.D., CEO of The Bizzell Group (Bizzell) celebrates the publication of the fifth edition of The ASAM Principles of Addiction Medicine.  The publication is the go-to textbook in the specialty field of addiction medicine, with the fifth edition providing core knowledge by “blending scientific principles underlying addiction with the practical essential of clinical addiction medicine.” The chapter, Ethical Issues in Addiction Practice was co-authored by Dr. Bizzell, H. Westley Clark, MD, JD, MPH, CAS, FASAM and Anthony Campbell, RPh, DO.

Dr. Bizzell brings significant experience within the health care community having served as a medical officer for the Substance Abuse and Mental Health Services Administration (SAMHSA) and with the National Institute on Alcohol Abuse and Alcoholism (NIAAA).   The chapter itself, details core ethical principles, aspects of dealing with denial, establishing an ethical stance, and potential future developments that could stimulate unprecedented paradigm shifts that may influence health care decision-making that would impact the disenfranchisement underlying health disparities in addiction treatment.

“It’s always an honor to be asked to participate in developing a narrative for something I’ve always been very passionate about,” Dr. Bizzell said in a statement.  “Its one thing to manage programs and work with people addressing addictive behaviors nationwide, but to be able to contribute to the field, and educate others is equally as rewarding. “

The ASAM Principles of Addiction Medicine Fifth Edition may be ordered through the publisher Lippincott Williams & Wilkins and includes a fully searchable online app version of the text and appendices and review questions. Phone orders dial 1-800-638-3030.

Bizzell CEO Appointed to COPE’s Governing Body

Bizzell CEO Appointed to COPE’s Governing Body

The Coalition on Physician Education in Substance Use Disorders’ (COPE) Executive Committee recently announced the appointment of Anton C. Bizzell, M.D., CEO of The Bizzell Group (Bizzell), to COPE’s governing body.  The designation adds to Dr. Bizzell’s rich history in the field of health education as he has served as a Medical Officer with the Substance Abuse and Mental Health Services Administration (SAMHSA), as well as in the Office of Translational Research and Education at the National Institute on Alcohol Abuse and Alcoholism (NIAAA), providing support for research and educational projects addressing physician and other allied health professions’ continuing education.

COPE was formed in 2010 to sustain and expand on the accomplishments of a series of White House Conferences on Medical Education in Substance Abuse, sponsored in 2003, 2006, and 2009 by the Office of National Drug Control Policy in the Executive Office of the President.  The organization’s overarching goal is to improve the education of medical students in the areas of alcohol, tobacco and other drug use disorders – ranging from problematic or risky use to addiction.  Another goal is to help medical students receive appropriate training to develop the skills they need to prevent, screen for, diagnose and manage substance use disorders in their patients, regardless of the location or specialty in which they ultimately practice.

As a member of COPE’s governing body Dr. Bizzell will have a hand in supporting the organization’s current activities including administration of medical school surveys and sponsorship of regional Medical Education Summits which are designed to identify specific needs and respond to opportunities for enhancing teaching about substance use disorders in the undergraduate years.  COPE also produces an e-newsletter, which is distributed to more than 3,000 readers, and maintains a website that offer news and resources to medical educators.

To learn more about COPE visit: www.cope-assn.org.